Session 3: Acute Leukemia
Tracks
Plenary Hall
| Thursday, October 8, 2026 |
| 2:50 PM - 4:40 PM |
Speaker
Prof. Farhad Ravandi-Kashani
Professor of Medicine and Chief of Section of Acute Myeloid Leukemia in the Department of Leukemia
The University of Texas MD Anderson Cancer Center
Genomic Risk Stratification in AML: From ELN 2022 to Practice
1:40 PM - 2:05 PMBiography
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
CAR-T Cell Therapy in Acute Leukemia: Access, Selection, and Outcomes
2:05 PM - 2:30 PMBiography
Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on >25 ongoing institutional, national and international clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical…in these diseases.
Prof. Farhad Ravandi-Kashani
Professor of Medicine and Chief of Section of Acute Myeloid Leukemia in the Department of Leukemia
The University of Texas MD Anderson Cancer Center
Chemo-Free and Low-Intensity Regimens in Adult ALL
2:30 PM - 2:55 PMBiography
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Targeted Therapies in AML: FLT3, IDH1/2, and Menin Inhibitors
2:55 PM - 3:20 PMBiography
Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on >25 ongoing institutional, national and international clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical…in these diseases.
Session Chair
Mahdiya Al Bulushi
Consultant Hematologist
The Royal Hospital
Murtadha Al Khabori
Senior Consultant, University Medical City
Professor of Hematology, Sultan Qaboos University
Mohammed Alhuneini
Senior Consultant Hematologist
University Medical City (NOCBMTH)